Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 5/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | PDE7A | Q13946 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | RORC | P51449 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15846974 | 0.99 | HSD17B10 (0.49) | HSD17B10MEN1KMT2ALMNASMN1; SMN2 | |
| Bromide SCHEMBL5828146 | 0.89 | HSD17B10 (0.47) | HSD17B10MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL15846972 | 0.84 | MEN1 (0.35) | MEN1KMT2ALMNASMN1; SMN2MAPT | |
| Bromide SCHEMBL17203097 | 0.84 | MAPT (0.44) | MEN1KMT2ALMNAPDE7AMAPT | |
| Bromide SCHEMBL980626 | 0.83 | ITGA4 (0.50) | MEN1KMT2ASMN1; SMN2MAPTALDH1A1 | |
| Bromide SCHEMBL2468888 | 0.83 | ALDH1A1 (0.45) | MEN1KMT2ALMNASMN1; SMN2MAPT | |
| SCHEMBL4402148 | 0.81 | ITGA4 (0.51) | MEN1KMT2ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL15848192 | 0.81 | ALDH1A1 (0.49) | MEN1KMT2ALMNAPDE7AMAPT | |
| Hydrochloric Acid SCHEMBL27872090 | 0.80 | ITGA4 (0.50) | MEN1KMT2ASMN1; SMN2MAPTALDH1A1 | |
| Bromide SCHEMBL5829133 | 0.80 | POLB (0.45) | MEN1KMT2ALMNAPDE7AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7094798-B1 | Inhibitors of checkpoint kinases (Wee1 and Chk1) | PFIZER INC (US) | 2006-08-22 | — | — | US | disclosed |
| EP-1501831-A1 | INHIBITORS OF CHECKPOINT KINASES (WEE1 AND CHK1) | WARNER-LAMBERT COMPANY LLC (US) | 2005-02-02 | — | — | EP | disclosed |
| WO-2003091255-A1 | INHIBITORS OF CHECKPOINT KINASES (WEE1 AND CHK1) | WARNER-LAMBERT COMPANY LLC (US) | 2003-11-06 | — | — | WO | disclosed |